ASX:RNO

Rhinomed Competitors

Add

Compare

Today's Range N/A

50-Day Range

A$0.07

MA: A$0.07▼

A$0.07

52-Week Range N/A

Volume452,773 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Rhinomed (ASX:RNO) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying RNO stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Rhinomed, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

Rhinomed vs. (CHV) Stock

Rhinomed (ASX:RNO) and (CHV) (CNSX:CHV) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, earnings, institutional ownership and valuation.

Profitability

This table compares Rhinomed and (CHV)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rhinomed	N/A	N/A	N/A
(CHV)	N/A	N/A	N/A

Earnings & Valuation

This table compares Rhinomed and (CHV)'s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rhinomed	$4.58 million	0.00	$-8,883,314.72	A($0.04)	N/A
(CHV)	N/A	N/A	N/A	N/A	N/A

(CHV) has lower revenue, but higher earnings than Rhinomed.

Analyst Ratings

This is a breakdown of recent ratings for Rhinomed and (CHV), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rhinomed	0	0	0	0	N/A
(CHV)	0	0	0	0	N/A

Summary

Rhinomed beats (CHV) on 1 of the 1 factors compared between the two stocks.

Rhinomed vs. (DDXS) Stock

Rhinomed (ASX:RNO) and (DDXS) (OTCMKTS:DDXS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, earnings, institutional ownership and valuation.

Analyst Ratings

This is a breakdown of recent ratings for Rhinomed and (DDXS), as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rhinomed	0	0	0	0	N/A
(DDXS)	0	0	0	0	N/A

Profitability

This table compares Rhinomed and (DDXS)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rhinomed	N/A	N/A	N/A
(DDXS)	N/A	N/A	N/A

Earnings & Valuation

This table compares Rhinomed and (DDXS)'s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rhinomed	$4.58 million	0.00	$-8,883,314.72	A($0.04)	N/A
(DDXS)	N/A	N/A	N/A	N/A	N/A

(DDXS) has lower revenue, but higher earnings than Rhinomed.

Summary

Rhinomed beats (DDXS) on 1 of the 1 factors compared between the two stocks.

Rhinomed vs. (PREV) Stock

(PREV) (CNSX:PREV) and Rhinomed (ASX:RNO) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.

Profitability

This table compares (PREV) and Rhinomed's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(PREV)	N/A	N/A	N/A
Rhinomed	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for (PREV) and Rhinomed, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(PREV)	0	0	0	0	N/A
Rhinomed	0	0	0	0	N/A

Earnings and Valuation

This table compares (PREV) and Rhinomed's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(PREV)	N/A	N/A	N/A	N/A	N/A
Rhinomed	$4.58 million	0.00	$-8,883,314.72	A($0.04)	N/A

(PREV) has higher earnings, but lower revenue than Rhinomed.

Summary

Rhinomed beats (PREV) on 1 of the 1 factors compared between the two stocks.

Rhinomed vs. (TNGN) Stock

(TNGN) (OTCMKTS:TNGN) and Rhinomed (ASX:RNO) are both health technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.

Valuation and Earnings

This table compares (TNGN) and Rhinomed's top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(TNGN)	N/A	N/A	N/A	N/A	N/A
Rhinomed	$4.58 million	0.00	$-8,883,314.72	A($0.04)	N/A

(TNGN) has higher earnings, but lower revenue than Rhinomed.

Profitability

This table compares (TNGN) and Rhinomed's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(TNGN)	N/A	N/A	N/A
Rhinomed	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent ratings and price targets for (TNGN) and Rhinomed, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(TNGN)	0	0	0	0	N/A
Rhinomed	0	0	0	0	N/A

Summary

Rhinomed beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Rhinomed vs. 138267 (COM.TO) Stock

Rhinomed (ASX:RNO) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership and profitability.

Earnings and Valuation

This table compares Rhinomed and 138267 (COM.TO)'s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rhinomed	$4.58 million	0.00	C$-8,883,314.72	A($0.04)	N/A
138267 (COM.TO)	N/A	N/A	N/A	N/A	N/A

138267 (COM.TO) has lower revenue, but higher earnings than Rhinomed.

Profitability

This table compares Rhinomed and 138267 (COM.TO)'s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rhinomed	N/A	N/A	N/A
138267 (COM.TO)	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Rhinomed and 138267 (COM.TO), as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rhinomed	0	0	0	0	N/A
138267 (COM.TO)	0	0	0	0	N/A

Summary

Rhinomed beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

Rhinomed vs. 17031 Stock

Rhinomed (ASX:RNO) and 17031 (CNSX:MYM) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, earnings, institutional ownership, dividends, analyst recommendations, valuation and profitability.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Rhinomed and 17031, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rhinomed	0	0	0	0	N/A
17031	0	0	0	0	N/A

Profitability

This table compares Rhinomed and 17031's net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rhinomed	N/A	N/A	N/A
17031	N/A	N/A	N/A

Earnings and Valuation

This table compares Rhinomed and 17031's revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rhinomed	$4.58 million	0.00	C$-8,883,314.72	A($0.04)	N/A
17031	N/A	N/A	N/A	N/A	N/A

17031 has lower revenue, but higher earnings than Rhinomed.

Summary

Rhinomed beats 17031 on 1 of the 1 factors compared between the two stocks.